Heparin-coated circuits prevent renal dysfunction after open heart surgery.

Area of Science:

• Cardiovascular Surgery
• Nephrology
• Biomaterials Science

Background:

• Chronic renal insufficiency poses risks during cardiac surgery.
• Cardiopulmonary bypass can exacerbate kidney dysfunction.

Purpose of the Study:

• To evaluate the efficacy of heparin-coated (HC) circuits in patients with chronic renal insufficiency undergoing cardiac surgery.
• To assess the impact of HC circuits on operative outcomes and renal function preservation.

Main Methods:

• Elective cardiac surgery was performed on 24 patients with serum creatinine ≥ 1.5 mg/dl.
• Patients were divided into two groups: 12 receiving uncoated circuits and 12 receiving HC circuits.
• Surgical results and renal function markers were compared between groups.

Main Results:

• The HC group had higher preoperative creatinine levels (2.3 vs 1.8 mg/dl).
• Lower heparin and protamine doses and shorter activated clotting times were observed in the HC group.
• The HC group showed a smaller postoperative increase in creatinine (2.3 to 2.5 mg/dl) compared to the non-coated group (1.8 to 2.3 mg/dl).
• No patients in the HC group with preoperative creatinine clearance < 20 ml/min required postoperative dialysis.

Conclusions:

• Heparin-coated circuits, combined with low-dose heparin, can preserve renal function post-cardiopulmonary bypass.
• HC circuits are a viable option for managing patients with severe kidney disease undergoing cardiac procedures.